Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Archelos

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Wiener Klinische Wochenschrift|May 12, 2007
[Treatment options in painful diabetic polyneuropathy]Juan J Archelos
Journal of Neurology|September 26, 2006
IVIG therapy in neurological disorders of childhoodJuan J Archelos, Franz Fazekas
Molecular Medicine Today|July 1, 1997
The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implicationsJ J Archelos, H P Hartung
Journal of Neurology|April 15, 2004
Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgGHalina Bartosik-Psujek, Juan J Archelos
Trends in Neurosciences|June 17, 2000
Pathogenetic role of autoantibodies in neurological diseasesJ J Archelos, H P Hartung
Journal of Clinical Psychopharmacology|September 23, 2000
Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: is the sigma receptor involved?A Schuld, J J Archelos, E Friess
Neuroscience Letters|December 6, 1997
Attenuation of experimental autoimmune neuritis in the Lewis rat by treatment with an antibody to L-selectinJ J Archelos, T Fortwängler, H P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Statins in multiple sclerosis: a new therapeutic option?O Neuhaus, J J Archelos, H P Hartung
Trends in Pharmacological Sciences|March 12, 2003
Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotectionOliver Neuhaus, Juan J Archelos, Hans-Peter Hartung
Nature Reviews. Neuroscience|April 23, 2002
New concepts in the immunopathogenesis of multiple sclerosisBernhard Hemmer, Juan J Archelos, Hans-Peter Hartung
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Wiener Klinische Wochenschrift|May 12, 2007
[Treatment options in painful diabetic polyneuropathy]Juan J Archelos
Journal of Neurology|September 26, 2006
IVIG therapy in neurological disorders of childhoodJuan J Archelos, Franz Fazekas
Molecular Medicine Today|July 1, 1997
The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implicationsJ J Archelos, H P Hartung
Journal of Neurology|April 15, 2004
Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgGHalina Bartosik-Psujek, Juan J Archelos
Trends in Neurosciences|June 17, 2000
Pathogenetic role of autoantibodies in neurological diseasesJ J Archelos, H P Hartung
Journal of Clinical Psychopharmacology|September 23, 2000
Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: is the sigma receptor involved?A Schuld, J J Archelos, E Friess
Neuroscience Letters|December 6, 1997
Attenuation of experimental autoimmune neuritis in the Lewis rat by treatment with an antibody to L-selectinJ J Archelos, T Fortwängler, H P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Statins in multiple sclerosis: a new therapeutic option?O Neuhaus, J J Archelos, H P Hartung
Trends in Pharmacological Sciences|March 12, 2003
Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotectionOliver Neuhaus, Juan J Archelos, Hans-Peter Hartung
Nature Reviews. Neuroscience|April 23, 2002
New concepts in the immunopathogenesis of multiple sclerosisBernhard Hemmer, Juan J Archelos, Hans-Peter Hartung
Pageof 7